22-12-2025 12:11
via
news.google.com
Aardvark Therapeutics, Inc.(NasdaqGS: AARD) added to NASDAQ Biotechnology Index - marketscreener.com
Aardvark Therapeutics, Inc.(NasdaqGS: AARD) added to NASDAQ Biotechnology Index marketscreener.com
Read more »
Biotechnology news
China's Otovia banks new cash for deafness gene therapy - The Pharma Letter
Integrated experimental and AI innovations for RNA structure determination - Nature
Sanofi seeks to widen Tzield’s reach with US priority review - The Pharma Letter
Moving beyond monogenic disorders in clinical healthcare - Nature
Axsome Therapeutics - The Pharma Letter
How biotechnology is turning the tide on UK water systems battling climate change - Water Magazine
Gene editing in Indonesia: can new biotechnology solve old agricultural problems? - The Conversation
Compilation Highlights Biotechnology Trends and Innovations of 2025 Released by BioCentury - geneonline.com
Protein Engineering for Pharmaceutical Biotechnology Training Course: Understand How to Advance Ther - PharmiWeb.com
Protein Engineering for Pharmaceutical Biotechnology Training Course: Understand How to Advance Therapeutic Development and Industrial Applications (Jan 21st - Jan 22nd, 2026) - ResearchAndMarkets.com - Bluefield Daily Telegraph
Corcept setback as relacorilant filing for hypercortisolism is rejected - The Pharma Letter
Pfizer discloses death in long-term Hympavzi study after thrombotic stroke - The Pharma Letter
Troubleshooting common errors in assemblies of long-read metagenomes - Nature
Single-strand deaminase-assisted editing for functional RNA manipulation - Nature
Desktop versie